Literature DB >> 5400154

[Glycoprotein metabolism in galactosamine-induced hepatitis].

W Reutter, D Keppler, R Lesch, K Decker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5400154

Source DB:  PubMed          Journal:  Verh Dtsch Ges Inn Med        ISSN： 0070-4067


× No keyword cloud information.
  6 in total

1.  [Histochemical determination of beta-glucuronidase(EC 3.2.1.31) and beta-acetylglucosaminidase(E.C.3.2.1.30) in rat liver after administration of 1-naphthyl-isothiocyanate and D-galactosamine hydrochloride].

Authors:  D Platt; M Platt
Journal:  Klin Wochenschr       Date:  1970-12-01

2.  [Distribution and activity of lysosomal protein catabolic-enzymes of rat liver in galactosamine hepatitis: catepsin D, cathepsin A and acid carboxypeptidase].

Authors:  U Stein; H Heismeyer; G Wangemann; R Lesch; W Reutter; D Keppler
Journal:  Klin Wochenschr       Date:  1971-05-01

3.  Reduced insulin binding to hepatic plasma membranes in D-galactosamine-treated rats.

Authors:  W Bachmann; M Haslbeck; I Böttger; K D Hepp; H Mehnert
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

4.  Studies on rat liver plasma membrane. Altered protein and phospholipid metabolism after injection of D-galactosamine.

Authors:  W Bachmann; E Harms; B Hassels; H Henninger; W Reuitter
Journal:  Biochem J       Date:  1977-09-15       Impact factor: 3.857

5.  Studies on the golgi apparatus. Cumulative inhibition of protein and glycoprotein secretion by D-galactosamine.

Authors:  C H Bauer; R Lukaschek; W G Reutter
Journal:  Biochem J       Date:  1974-08       Impact factor: 3.857

6.  Prevention of galactosamine-induced liver cell necrosis by uridine.

Authors:  J L Farber; G Gill; Y Konishi
Journal:  Am J Pathol       Date:  1973-07       Impact factor: 4.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.